The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Yates, Chris Henry Francis
    Director born in February 1974
    Individual (9 offsprings)
    Officer
    2022-06-28 ~ now
    OF - Director → CIF 0
    Yates, Chris
    Individual (9 offsprings)
    Officer
    2023-10-18 ~ now
    OF - Secretary → CIF 0
  • 2
    ABINGDON HEALTH LTD - 2020-11-11
    York Biotech Campus, Sand Hutton, York, England
    Active Corporate (4 parents, 7 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 28
  • 1
    Bradley, Donal Donat Conor, Professor
    Professor born in January 1962
    Individual (2 offsprings)
    Officer
    2001-11-27 ~ 2012-03-22
    OF - Director → CIF 0
  • 2
    De Mello, Andrew James, Dr
    University Lecturer born in March 1970
    Individual
    Officer
    2001-11-27 ~ 2007-07-30
    OF - Director → CIF 0
  • 3
    Richards, Jemima
    Technology Transfer Executive born in November 1973
    Individual
    Officer
    2001-11-27 ~ 2002-07-30
    OF - Director → CIF 0
  • 4
    Woodford, Peter
    Business Consultant born in August 1948
    Individual
    Officer
    2009-02-01 ~ 2015-03-17
    OF - Director → CIF 0
  • 5
    Tobin, Jonathan Leslie, Dr
    Venture Capitalist born in December 1982
    Individual (6 offsprings)
    Officer
    2013-08-13 ~ 2016-06-23
    OF - Director → CIF 0
  • 6
    Atun, Rifat Ali, Prof.
    Academic born in February 1962
    Individual (1 offspring)
    Officer
    2005-05-05 ~ 2007-07-30
    OF - Director → CIF 0
  • 7
    Byrne, Kevin
    Solicitor born in September 1966
    Individual (1 offspring)
    Officer
    2001-09-24 ~ 2001-11-27
    OF - Director → CIF 0
  • 8
    Topoglidis, Emmanuel, Dr
    Cto Of Acron Genomics born in August 1973
    Individual
    Officer
    2008-11-13 ~ 2012-03-22
    OF - Director → CIF 0
  • 9
    Bhaman, Maina
    Investment Manager born in February 1972
    Individual (5 offsprings)
    Officer
    2008-04-21 ~ 2012-03-22
    OF - Director → CIF 0
  • 10
    Cairns, Judith
    Individual
    Officer
    2006-10-18 ~ 2009-09-24
    OF - Secretary → CIF 0
  • 11
    Wright, Christopher John, Dr
    Director born in December 1947
    Individual (6 offsprings)
    Officer
    2006-11-01 ~ 2010-02-26
    OF - Director → CIF 0
  • 12
    Poulios, Constas
    Lawyer born in October 1972
    Individual
    Officer
    2009-05-13 ~ 2009-08-17
    OF - Director → CIF 0
    2009-11-16 ~ 2012-03-22
    OF - Director → CIF 0
  • 13
    Campbell, Ian William, Dr
    Managing Director born in July 1972
    Individual (2 offsprings)
    Officer
    2007-08-22 ~ 2011-01-31
    OF - Director → CIF 0
  • 14
    Page, Scott Andrew
    Individual (1 offspring)
    Officer
    2019-09-11 ~ 2022-06-28
    OF - Secretary → CIF 0
  • 15
    Todd, Rebecca, Dr
    Investment Manager born in March 1973
    Individual
    Officer
    2012-03-22 ~ 2013-07-12
    OF - Director → CIF 0
  • 16
    Hand, Christopher William, Dr
    Company Director born in May 1961
    Individual (4 offsprings)
    Officer
    2010-03-08 ~ 2021-04-20
    OF - Director → CIF 0
  • 17
    Bateman, Malcolm Richard
    Individual
    Officer
    2009-10-19 ~ 2012-01-05
    OF - Secretary → CIF 0
  • 18
    Marlow, Richard James
    Individual (4 offsprings)
    Officer
    2014-05-19 ~ 2019-09-11
    OF - Secretary → CIF 0
  • 19
    De Mello, John, Dr
    Academic born in July 1973
    Individual (1 offspring)
    Officer
    2007-07-30 ~ 2009-07-09
    OF - Director → CIF 0
    2009-08-20 ~ 2012-03-22
    OF - Director → CIF 0
  • 20
    Garraway, Richard, Dr
    Director born in February 1966
    Individual (13 offsprings)
    Officer
    2005-05-05 ~ 2007-10-30
    OF - Director → CIF 0
  • 21
    Ross, Melanie
    Chief Financial Officer born in October 1979
    Individual (2 offsprings)
    Officer
    2021-04-20 ~ 2023-10-18
    OF - Director → CIF 0
    Ross, Melanie
    Individual (2 offsprings)
    Officer
    2022-06-28 ~ 2023-10-18
    OF - Secretary → CIF 0
  • 22
    Paterson, Alexander Nicholas
    Individual (2 offsprings)
    Officer
    2001-09-24 ~ 2006-10-18
    OF - Secretary → CIF 0
  • 23
    Hofmann, Oliver, Dr
    Company Director born in April 1972
    Individual (1 offspring)
    Officer
    2014-09-29 ~ 2015-11-30
    OF - Director → CIF 0
  • 24
    Searle, Susan Jane
    Commercial Director born in April 1963
    Individual (6 offsprings)
    Officer
    2001-11-27 ~ 2003-04-27
    OF - Director → CIF 0
  • 25
    Ainsworth, Peter James, Dr
    Technology Transfer born in June 1970
    Individual
    Officer
    2003-05-27 ~ 2005-05-05
    OF - Director → CIF 0
  • 26
    26, Church Street, London
    Dissolved Corporate (4 parents, 10 offsprings)
    Equity (Company account)
    2 GBP2022-12-31
    Officer
    2001-09-24 ~ 2001-09-24
    PE - Nominee Secretary → CIF 0
  • 27
    1, Mitchell Lane, Bristol, Avon
    Dissolved Corporate (4 parents, 15 offsprings)
    Equity (Company account)
    100 GBP2022-12-31
    Officer
    2001-09-24 ~ 2001-09-24
    PE - Nominee Director → CIF 0
  • 28
    IMPERIAL INNOVATIONS BUSINESSES LLP - 2017-01-04
    52, Princes Gate, London, England
    Active Corporate (47 parents, 14 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-05-11
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

MOLECULAR VISION LIMITED

Previous name
MELECULAR VISION LIMITED - 2001-09-27
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Other Interest Receivable/Similar Income (Finance Income)
2,856 GBP2023-07-01 ~ 2024-06-30
1,836 GBP2022-07-01 ~ 2023-06-30
Interest Payable/Similar Charges (Finance Costs)
-90,247 GBP2023-07-01 ~ 2024-06-30
-90,000 GBP2022-07-01 ~ 2023-06-30
Profit/Loss on Ordinary Activities Before Tax
-133,875 GBP2023-07-01 ~ 2024-06-30
-100,158 GBP2022-07-01 ~ 2023-06-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
0 GBP2023-07-01 ~ 2024-06-30
0 GBP2022-07-01 ~ 2023-06-30
Profit/Loss
-133,875 GBP2023-07-01 ~ 2024-06-30
-100,158 GBP2022-07-01 ~ 2023-06-30
Intangible Assets
Other
3,751 GBP2024-06-30
13,609 GBP2023-06-30
Property, Plant & Equipment
0 GBP2024-06-30
0 GBP2023-06-30
Fixed Assets
3,751 GBP2024-06-30
13,609 GBP2023-06-30
Debtors
0 GBP2024-06-30
31,875 GBP2023-06-30
Cash at bank and in hand
70,828 GBP2024-06-30
68,170 GBP2023-06-30
Current Assets
70,828 GBP2024-06-30
100,045 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-239,506 GBP2024-06-30
-234,952 GBP2023-06-30
Net Current Assets/Liabilities
-168,678 GBP2024-06-30
-134,907 GBP2023-06-30
Total Assets Less Current Liabilities
-164,927 GBP2024-06-30
-121,298 GBP2023-06-30
Creditors
Non-current, Amounts falling due after one year
-1,810,212 GBP2024-06-30
-1,719,966 GBP2023-06-30
Net Assets/Liabilities
-1,975,139 GBP2024-06-30
-1,841,264 GBP2023-06-30
Equity
Called up share capital
574 GBP2024-06-30
574 GBP2023-06-30
574 GBP2022-06-30
Share premium
4,662,966 GBP2024-06-30
4,662,966 GBP2023-06-30
4,662,966 GBP2022-06-30
Retained earnings (accumulated losses)
-6,638,679 GBP2024-06-30
-6,504,804 GBP2023-06-30
-6,404,646 GBP2022-06-30
Equity
-1,975,139 GBP2024-06-30
-1,841,264 GBP2023-06-30
-1,741,106 GBP2022-06-30
Profit/Loss
Retained earnings (accumulated losses)
-133,875 GBP2023-07-01 ~ 2024-06-30
-100,158 GBP2022-07-01 ~ 2023-06-30
Average Number of Employees
12023-07-01 ~ 2024-06-30
22022-07-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
13,860 GBP2024-06-30
23,692 GBP2023-06-30
Development expenditure
230,204 GBP2024-06-30
230,204 GBP2023-06-30
Intangible Assets - Gross Cost
244,064 GBP2024-06-30
253,896 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
10,109 GBP2024-06-30
10,083 GBP2023-06-30
Development expenditure
230,204 GBP2024-06-30
230,204 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
240,313 GBP2024-06-30
240,287 GBP2023-06-30
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
6,466 GBP2023-07-01 ~ 2024-06-30
Development expenditure
0 GBP2023-07-01 ~ 2024-06-30
Intangible Assets - Increase From Amortisation Charge for Year
6,466 GBP2023-07-01 ~ 2024-06-30
Intangible Assets
Patents/Trademarks/Licences/Concessions
3,751 GBP2024-06-30
13,609 GBP2023-06-30
Development expenditure
0 GBP2024-06-30
0 GBP2023-06-30
Intangible Assets
3,751 GBP2024-06-30
13,609 GBP2023-06-30
Amounts Owed by Group Undertakings
Current
0 GBP2024-06-30
26,780 GBP2023-06-30
Prepayments/Accrued Income
Current
0 GBP2024-06-30
5,095 GBP2023-06-30
Debtors
Current, Amounts falling due within one year
0 GBP2024-06-30
31,875 GBP2023-06-30
Amounts owed to group undertakings
Current
169,545 GBP2024-06-30
166,575 GBP2023-06-30
Other Creditors
Current
67,308 GBP2024-06-30
67,308 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
2,653 GBP2024-06-30
1,069 GBP2023-06-30
Creditors
Current
239,506 GBP2024-06-30
234,952 GBP2023-06-30
Other Remaining Borrowings
Non-current
1,810,212 GBP2024-06-30
1,719,966 GBP2023-06-30

  • MOLECULAR VISION LIMITED
    Info
    MELECULAR VISION LIMITED - 2001-09-27
    Registered number 04292847
    York Biotech Campus, Sand Hutton, York YO41 1LZ
    Private Limited Company incorporated on 2001-09-24 (23 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.